This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Primatenzentrum Gmbh Leibniz-Institut Für Primatenforschung. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations of Julian Plaga in Virus Targeting Technology
Introduction
Julian Plaga is an innovative inventor based in Hamburg, Germany. He has made significant contributions to the field of virology, particularly in the development of methods for targeting viruses and virus-like particles (VLPs). His work has the potential to advance medical treatments and therapeutic applications.
Latest Patents
Julian Plaga holds a patent for a method of producing a polyomavirus or polyomavirus-derived virus-like particle that carries at least one targeting molecule on its surface. This invention is designed to bind to specific cells of interest, enhancing the effectiveness of medical treatments. The patent also includes a composition comprising such a polyomavirus or VLP, which can be utilized as a medicament. Additionally, the invention encompasses a kit that includes the polyomavirus or VLP or the composition.
Career Highlights
Julian Plaga is associated with the Deutsches Primatenzentrum GmbH Leibniz-Institut für Primatenforschung, where he conducts his research and development activities. His work is characterized by a focus on innovative solutions in the field of virology, contributing to advancements in medical science.
Collaborations
Julian collaborates with notable colleagues, including Arnd Steuernagel and Alina Mosblech. Their combined expertise fosters a productive research environment that enhances the potential for groundbreaking discoveries.
Conclusion
Julian Plaga's innovative work in virus targeting technology exemplifies the intersection of science and medicine. His contributions are paving the way for new therapeutic approaches that could significantly impact healthcare.